These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35505833)

  • 21. Case Report: A case of multisystem inflammatory syndrome in an 11-year-old female after COVID-19 inactivated vaccine.
    Saeed S; Cao J; Xu J; Zhang Y; Zheng X; Jiang L; Jiang C; Zhang X
    Front Pediatr; 2023; 11():1068301. PubMed ID: 36865693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Sacco C; Del Manso M; Mateo-Urdiales A; Rota MC; Petrone D; Riccardo F; Bella A; Siddu A; Battilomo S; Proietti V; Popoli P; Menniti Ippolito F; Palamara AT; Brusaferro S; Rezza G; Pezzotti P; Fabiani M;
    Lancet; 2022 Jul; 400(10346):97-103. PubMed ID: 35780801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
    LaRovere KL; Poussaint TY; Young CC; Newhams MM; Kucukak S; Irby K; Kong M; Schwartz SP; Walker TC; Bembea MM; Wellnitz K; Havlin KM; Cvijanovich NZ; Hall MW; Fitzgerald JC; Schuster JE; Hobbs CV; Halasa NB; Singh AR; Mack EH; Bradford TT; Gertz SJ; Schwarz AJ; Typpo KV; Loftis LL; Giuliano JS; Horwitz SM; Biagas KV; Clouser KN; Rowan CM; Maddux AB; Soma VL; Babbitt CJ; Aguiar CL; Kolmar AR; Heidemann SM; Harvey H; Zambrano LD; Campbell AP; Randolph AG;
    JAMA Neurol; 2023 Jan; 80(1):91-98. PubMed ID: 36342679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of multisystem inflammatory syndrome and other autoimmune diseases after SARS-CoV-2 infection compared to COVID-19 vaccination in children and adolescents in south central Europe.
    Bizjak M; Emeršič N; Zajc Avramovič M; Barbone F; Ronchese F; Della Paolera S; Conversano E; Amoroso S; Vidoni M; Vesel Tajnšek T; Mlakar G; Berce V; Markelj G; Plankar Srovin T; Golli T; Osredkar D; Koren Jeverica A; Toplak N; Pokorn M; Avšič Županc T; Ihan A; Fafangel M; Taddio A; Avčin T
    Clin Exp Rheumatol; 2023 May; 41(5):1183-1191. PubMed ID: 36377567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Multisystem Inflammatory Syndrome in Children"-Like Disease after COVID-19 Vaccination (MIS-V) with Potential Significance of Functional Active Autoantibodies Targeting G-Protein-Coupled Receptors (GPCR-fAAb) for Pathophysiology and Therapy.
    Schmidt M; Hébert S; Wallukat G; Ponader R; Krickau T; Galiano M; Reutter H; Woelfle J; Agaimy A; Mardin C; Hoerning A; Hohberger B
    Children (Basel); 2023 Nov; 10(12):. PubMed ID: 38136038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination-Induced Myocarditis.
    Patel H; Sintou A; Chowdhury RA; Rothery S; Iacob AO; Prasad S; Rainer PP; Martinón-Torres F; Sancho-Shimizu V; Shimizu C; Dummer K; Tremoulet AH; Burns JC; Sattler S; Levin M;
    JAMA Netw Open; 2023 May; 6(5):e2314291. PubMed ID: 37200028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
    Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An 11-Year-Old Saudi Arabian Girl Who Presented with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 Infection with Coronary Artery Aneurysm and Cardiac Involvement: A Case Report.
    Al Qahtani M; Uddin MS; Al Fulayyih S; Al Baridi S; Hamid Z
    Am J Case Rep; 2021 Sep; 22():e933053. PubMed ID: 34510156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey.
    Minoia F; Lucioni F; Heshin-Bekenstein M; Vastert S; Kessel C; Uziel Y; Lamot L; Ruperto N; Gattorno M; Bracaglia C; Toplak N
    Front Pediatr; 2022; 10():1030083. PubMed ID: 36440337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Vaccination in Two Children.
    Karatzios C; Scuccimarri R; Chédeville G; Basfar W; Bullard J; Stein DR
    Pediatrics; 2022 Aug; 150(2):. PubMed ID: 35614536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination.
    Collignon C; Frachette C; Callot D; Pinhas Y; Bataille P; Bader-Meunier B; Chouchana L; Frémond ML; Belhadjer Z; Oualha M; Moulin F; Javouhey E; Belot A; Renolleau S
    Arch Pediatr; 2022 Nov; 29(8):620-623. PubMed ID: 36283888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
    More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
    Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Active Surveillance With Seroprevalence-based Infection Rates Indicates Racial Disparities With Pediatric SARS-CoV-2 Requiring Hospitalization in Mississippi, March 2020-February 2021.
    Hobbs CV; Kim SS; Vemula P; Inagaki K; Harrison VA; Malloch L; Martin LM; Singh G; Agana U; Williams JM; Patterson K; Kittle T; Byers P; Palmer A; Santos RP; Dhanrajani A; Stephenson M; Hung L; Hankins P; Thornburg N; Drobeniuc J; Flannery B;
    Pediatr Infect Dis J; 2022 Sep; 41(9):736-741. PubMed ID: 35703309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.
    Chemaitelly H; Ayoub HH; AlMukdad S; Coyle P; Tang P; Yassine HM; Al-Khatib HA; Smatti MK; Hasan MR; Al-Kanaani Z; Al-Kuwari E; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Butt AA; Al-Romaihi HE; Al-Thani MH; Al-Khal A; Bertollini R; Abu-Raddad LJ
    Lancet Microbe; 2022 Dec; 3(12):e944-e955. PubMed ID: 36375482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multisystem inflammatory syndrome in children during the coronavirus disease 2019 (COVID-19) pandemic: a systematic review of published case studies.
    Tang Y; Li W; Baskota M; Zhou Q; Fu Z; Luo Z; Shi Y; Chen Y; Liu E
    Transl Pediatr; 2021 Jan; 10(1):121-135. PubMed ID: 33633944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multisystem Inflammatory Syndrome in an Adolescent Following SARS-CoV-2 Exposure Despite Three Doses of a COVID-19 Vaccine.
    Goel AR; Chiang SS; Ibrahim O; Yalcindag A
    R I Med J (2013); 2022 Jun; 105(5):41-45. PubMed ID: 35617041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Updated Management Protocol for Multisystem Inflammatory Syndrome in Children (MIS-C).
    Takia L; Angurana SK; Nallasamy K; Bansal A; Muralidharan J
    J Trop Pediatr; 2021 Jul; 67(3):. PubMed ID: 34414434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis.
    Noval Rivas M; Porritt RA; Cheng MH; Bahar I; Arditi M
    Front Immunol; 2022; 13():941009. PubMed ID: 35874696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children.
    Avcu G; Arslan SY; Soylu M; Bilen NM; Bal ZS; Cicek C; Kurugol Z; Ozkinay F
    Viral Immunol; 2022 Dec; 35(10):681-689. PubMed ID: 36534467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study.
    Zinzi A; Gaio M; Liguori V; Ruggiero R; Tesorone M; Rossi F; Rafaniello C; Capuano A
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.